학술논문
PD‐1‐specific "Blocking" antibodies that deplete PD‐1+ T cells present an inconvenient variable in preclinical immunotherapy experiments.
Document Type
Article
Author
Source
European Journal of Immunology; Jun2021, Vol. 51 Issue 6, p1473-1481, 9p
Subject
Language
ISSN
00142980
Abstract
Copyright of European Journal of Immunology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)